Table 1.
Characteristic | N (%) |
---|---|
Menopausal status | |
Premenopausal | 34 (44.7) |
Postmenopausal | 42 (55.3) |
Race/Ethnicity | |
White | 65 (85.5) |
Asian | 1 (1.3) |
Hispanic | 7 (9.2) |
African American | 3 (4) |
ER | |
Negative | 39 (51.3) |
Positive | 37 (48.7) |
PR | |
Negative | 40 (52.6) |
Positive | 36 (47.4) |
Response to trastuzumab‐based chemotherapy | |
Stable disease | 29 (38.2) |
Partial response | 21 (27.6) |
Progressive disease | 26 (34.2) |